Malta - engelsk - Medicines Authority

nm pharma limited 3/4, cantrija complex triq it-targa, il-maghtab naxxar nxr 6613 , malta - valsartan - film-coated tablet - valsartan 160 mg - agents acting on the renin-angiotensin system

Armenia - engelsk - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

siegfried barbera s.l. - valsartan - tablets film-coated - 160mg

Armenia - engelsk - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

novartis farma s.p.a - valsartan - tablets film-coated - 160mg

Taiwan - kinesisk - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣諾華股份有限公司 台北市中山區民生東路三段2號8樓 (01516589) - valsartan - 膜衣錠 - valsartan (2408005100) mg - valsartan - 治療成人和6-18 歲的兒童或青少年高血壓、心衰竭(nyha 二到四級)、心肌梗塞後左心室功能異常。

USA - engelsk - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - valsartan (unii: 80m03yxj7i) (valsartan - unii:80m03yxj7i) - valsartan 160 mg - diovan ® is indicated for the treatment of hypertension, to lower blood pressure in adults and pediatric patients one year of age and older. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including the class to which valsartan principally belongs. there are no controlled trials in hypertensive patients demonstrating risk reduction with diovan. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education progr

Kypros - gresk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

generics pharma hellas ltd (0000003679) 63, ag. dimitriou str., alimos, athens, 17456 - valsartan - film coated tablets - 160mg - valsartan (8000001531) 160mg

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - hydrochlorothiazide 25mg;  ; valsartan 160mg;  ;  ;   - film coated tablet - 25mg/160mg - active: hydrochlorothiazide 25mg   valsartan 160mg       excipient: colloidal silicon dioxide crospovidone hypromellose iron oxide black iron oxide red iron oxide yellow macrogol 8000 magnesium stearate microcrystalline cellulose purified talc purified water titanium dioxide - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. these fixed dose combinations should be used as second line.

Malta - engelsk - Medicines Authority

krka dd novo mesto Šmarješka cesta 6, 8501 novo mesto, slovenia - valsartan - film-coated tablet - valsartan 160 mg - agents acting on the renin-angiotensin system

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - valsartan; hydrochlorothiazide - tablet - 160mg ; 25mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - valsartan; hydrochlorothiazide - tablet - 160mg ; 25mg